Lack of hypophagia in CB1 null mice is associated to decreased Hypothalamic POMC and CART

International Journal of Neuropsychopharmacology

Volumn 18, Issue 9, 2015, Pages 1-6

  Lage, Ricardo ^a,b,c   Parisi, Claudia ^a,d   Seoane Collazo, Patricia ^a,b   Fernø, Johan ^a,e   Mazza, Roberta ^d   Bosch, Fátima ^c   Seoane, Luisa M ^b,f   Nogueiras, Ruben ^a,b   Diéguez, Carlos ^a,b   Quarta, Carmelo ^d   López, Miguel ^a,b  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^b Instituto de Salud Carlos III   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d UNIVERSITY OF BOLOGNA   (Italy)

^e UNIVERSITY OF BERGEN   (Norway)

^f HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

CART; CB1; Food intake; Hypothalamus; POMC

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N MORPHOLINO 1H PYRAZOLE 3 CARBOXAMIDE; COCAINE AMPHETAMINE REGULATED TRANSCRIPT; GHRELIN; MELANOCORTIN; MESSENGER RNA; NEUROPEPTIDE; PROOPIOMELANOCORTIN; UNCLASSIFIED DRUG; CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR ANTAGONIST; COCAINE AND AMPHETAMINE REGULATED TRANSCRIPT PEPTIDE; NERVE PROTEIN;

ADULT; ANIMAL EXPERIMENT; ARCUATE NUCLEUS; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; FOOD INTAKE; HYPOPHAGIA; HYPOTHALAMUS; IN SITU HYBRIDIZATION; LIPID DIET; MALE; MOUSE; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; ANIMAL; ANIMAL BEHAVIOR; ANOREXIA; ANTAGONISTS AND INHIBITORS; C57BL MOUSE; DEFICIENCY; DISEASE MODEL; FEEDING BEHAVIOR; GENETICS; KNOCKOUT MOUSE; METABOLISM; PHYSIOLOGY;

ANIMALS; ANOREXIA; ARCUATE NUCLEUS OF HYPOTHALAMUS; BEHAVIOR, ANIMAL; BODY WEIGHT; CANNABINOID RECEPTOR ANTAGONISTS; DISEASE MODELS, ANIMAL; FEEDING BEHAVIOR; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NERVE TISSUE PROTEINS; PRO-OPIOMELANOCORTIN; RECEPTOR, CANNABINOID, CB1;

EID: 84953257968     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1093/ijnp/pyv011     Document Type: Article

References (25)

1. Alen F, Ramirez-López MT, Gomez de Heras R, Rodriguez de Fonseca F, Orio L (2013) Cannabinoid receptors and cholecystokinin in feeding inhibition. Vitam Horm 92:165-196.
2. Bermudez-Silva F.J., Viveros MP, McPartland J.M., Rodriguez de Fonseca F (2010) The endocannabinoid system, eating behavior and energy homeostasis: the end or a new beginning? Pharmacol Biochem Behav 95:375-382.
3. Bermudez-Silva F.J., Cardinal P, Cota D. (2012) The role of the endocannabinoid system in the neuroendocrine regulation of energy balance. J Psychopharmacol 26:114-124.
4. Colombo G, Agabio R, Diaz G., Lobina C, Reali R, Gessa G.L. (1998) Appetite suppression and weight loss after the cannabinoid antagonist SR 141716. Life Sci 63:PL113-117.
5. Cota D, Marsicano G, Tschop M., Grubler Y, Flachskamm C, Schubert M., Auer D, Yassouridis A, Thone-Reineke C, Ortmann S., Tomassoni F, Cervino C, Nisoli E., Linthorst AC, Pasquali R, Lutz B, Stalla GK, Pagotto U (2003) The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis. J Clin Invest 112:423-431.
6. Di Marzo V., Ligresti A, Cristino L. (2009) The endocannabinoid system as a link between homoeostatic and hedonic pathways involved in energy balance regulation. Int J Obes (Lond) 33(Supp 2): S18-24.
7. Jamshidi N, Taylor D.A. (2001) Anandamide administration into the ventromedial hypothalamus stimulates appetite in rats. Br J Pharmacol 134:1151-1154.
8. Jbilo O, Ravinet-Trillou C, Arnone M., Buisson I, Bribes E, Peleraux A., Penarier G, Soubrie P, Le Fur G, Galiegue S, Casellas P. (2005) The CB1 receptor antagonist rimonabant reverses the dietinduced obesity phenotype through the regulation of lipolysis and energy balance. FASEB J 19:1567-1569.
9. Lage R, Vazquez MJ, Varela L, Saha A.K., Vidal-Puig A, Nogueiras R, Dieguez C., López M (2010) Ghrelin effects on neuropeptides in the rat hypothalamus depend on fatty acid metabolism actions on BSX but not on gender. FASEB J 24:2670-2679.
10. López M et al. (2008) Hypothalamic fatty acid metabolism mediates the orexigenic action of ghrelin. Cell Metab 7:389-399.
11. López M et al. (2010) Hypothalamic AMPK and fatty acid metabolism mediate thyroid regulation of energy balance. Nat Med 16:1001-1008.
12. Marsicano G, Goodenough S, Monory K., Hermann H, Eder M, Cannich A., Azad SC, Cascio MG, Gutierrez SO, van der Stelt M, López-Rodriguez ML, Casanova E, Schutz G, Zieglgansberger W, Di Marzo V, Behl C, Lutz B (2003) CB1 cannabinoid receptors and on-demand defense against excitotoxicity. Science 302:84-88.
13. Martinez de Morentin PB, Gonzalez-Garcia I, Martins L., Lage R, Fernandez-Mallo D, Martinez-Sanchez N, Ruiz-Pino F, Liu J, Morgan D.A., Pinilla L., Gallego R, Saha AK, Kalsbeek A, Fliers E, Bisschop PH, Dieguez C, Nogueiras R, Rahmouni K, Tena-Sempere M, López M (2014) Estradiol regulates brown adipose tissue ther-mogenesis via hypothalamic AMPK. Cell Metab 20:41-53.
14. Nogueiras R, Veyrat-Durebex C, Suchanek P.M., Klein M., Tschop J, Caldwell C, Woods S.C., Wittmann G., Watanabe M, Liposits Z, Fekete C., Reizes O, Rohner-Jeanrenaud F, Tschop M.H. (2008) Peripheral, but not central, CB1 antagonism provides food intake-independent metabolic benefits in diet-induced obese rats. Diabetes 57:2977-2991.
15. Osei-Hyiaman D., Depetrillo M, Harvey-White J, Bannon A.W., Cravatt BF, Kuhar MJ, Mackie K, Palkovits M., Kunos G. (2005) Cocaine- and amphetamine-related transcript is involved in the orexigenic effect of endogenous anandamide. Neuroen-docrinology 81:273-282.
16. Quarta C et al. (2010) CB(1) signaling in forebrain and sympathetic neurons is a key determinant of endocannabinoid actions on energy balance. Cell Metab 11:273-285.
17. Quarta C, Mazza R, Obici S., Pasquali R, Pagotto U. (2011) Energy balance regulation by endocannabinoids at central and peripheral levels. Trends Mol Med 17:518-526.
18. Ravinet Trillou C., Delgorge C, Menet C., Arnone M, Soubrie P. (2004) CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity. Int J Obes Relat Metab Disord 28:640-648.
19. Rorato R, Miyahara C, Antunes-Rodrigues J, Elias L.L. (2013) Tolerance to hypophagia induced by prolonged treatment with a CB1 antagonist is related to the reversion of anorexigenic neuropeptide gene expression in the hypothalamus. Regul Pept 182:12-18.
20. Silvestri C, Di Marzo V (2013) The endocannabinoid system in energy homeostasis and the etiopathology of metabolic disorders. Cell Metab 17:475-490.
21. Sinnayah P, Jobst EE, Rathner J.A., Caldera-Siu AD, Tonelli-Lemos L, Eusterbrock A.J., Enriori PJ, Pothos EN, Grove KL, Cowley M.A. (2008) Feeding induced by cannabinoids is mediated independently of the melanocortin system. PLOS ONE 3:e2202.
22. Soria-Gomez E., Massa F, Bellocchio L., Rueda-Orozco PE, Ciofi P, Cota D., Oliet SH, Prospero-Garcia O, Marsicano G. (2014) Cannabinoid type-1 receptors in the paraventricular nucleus of the hypothalamus inhibit stimulated food intake. Neuroscience 263:46-53.
23. Verty AN, McFarlane JR, McGregor I.S., Mallet P.E. (2004) Evidence for an interaction between CB1 cannabinoid and melanocortin MCR-4 receptors in regulating food intake. Endocrinology 145:3224-3231.
24. Verty AN, McGregor IS, Mallet P.E. (2005) Paraventricular hypothalamic CB(1) cannabinoid receptors are involved in the feeding stimulatory effects of Delta(9)-tetrahydrocannabinol. Neuropharmacology 49:1101-1109.
25. Verty AN, Boon WM, Mallet P.E., McGregor IS, Oldfield B.J. (2009) Involvement of hypothalamic peptides in the anorectic action of the CB receptor antagonist rimonabant (SR 141716). Eur J Neurosci 29:2207-2216.